{"id":"https://openalex.org/W4310103689","doi":"https://doi.org/10.1182/blood-2022-164443","title":"Sequential Administration of Selinexor then CD19 CAR-T Cells Exhibits Enhanced Efficacy in a Mouse Model of Human Non-Hodgkin's Lymphoma","display_name":"Sequential Administration of Selinexor then CD19 CAR-T Cells Exhibits Enhanced Efficacy in a Mouse Model of Human Non-Hodgkin's Lymphoma","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310103689","doi":"https://doi.org/10.1182/blood-2022-164443"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-164443","doi":"https://doi.org/10.1182/blood-2022-164443","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-164443","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Ryan Stadel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan Stadel","raw_affiliation_strings":["1CuronBiotech Inc., cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CuronBiotech Inc., cleveland, OH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005357880","display_name":"Ruifu Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruifu Liu","raw_affiliation_strings":["2Case Western Reserve University, Cleveland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Case Western Reserve University, Cleveland,","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057755017","display_name":"Yosef Landesman","orcid":"https://orcid.org/0000-0001-5542-5098","observed_orcids":["https://orcid.org/0000-0001-5542-5098"]},"institutions":[{"id":"https://openalex.org/I4210152529","display_name":"Karyopharm Therapeutics (United States)","ror":"https://ror.org/04ty78924","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152529"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yosef Landesman","raw_affiliation_strings":["3Karyopharm Therapeutics Inc., Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Karyopharm Therapeutics Inc., Newton, MA","institution_ids":["https://openalex.org/I4210152529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005791561","display_name":"David N. Wald","orcid":"https://orcid.org/0000-0002-8695-1178","observed_orcids":["https://orcid.org/0000-0002-8695-1178"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Wald","raw_affiliation_strings":["4Case Western Reserve University, Cleveland, OH","5Curonbiotech, Cleveland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I58956616"]},{"raw_affiliation_string":"5Curonbiotech, Cleveland,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108284413","display_name":"Smitha Hosahalli Vasanna","orcid":"https://orcid.org/0000-0002-5374-5888","observed_orcids":["https://orcid.org/0000-0002-5374-5888"]},"institutions":[{"id":"https://openalex.org/I4210151235","display_name":"Rainbow Babies & Children's Hospital","ror":"https://ror.org/04x495f64","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210151235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Smitha Hosahalli Vasanna","raw_affiliation_strings":["6Rainbow Babies and Childrens Hospital, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Rainbow Babies and Childrens Hospital, Cleveland, OH","institution_ids":["https://openalex.org/I4210151235"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104009994","display_name":"Marcos J.G. De Lima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcos J.G. de Lima","raw_affiliation_strings":["7Blood and Marrow and Cellular Therapy Program, Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Blood and Marrow and Cellular Therapy Program, Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.9328,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.75534156,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"7413","last_page":"7414"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selinexor","display_name":"selinexor","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cd19-car-t-cells","display_name":"CD19 CAR T cells","score":0.9919999837875366},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9789999723434448},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/sequential-administration","display_name":"sequential administration","score":0.6850000023841858},{"id":"https://openalex.org/keywords/exportin-1-inhibition","display_name":"exportin 1 inhibition","score":0.8119999766349792},{"id":"https://openalex.org/keywords/nuclear-export-inhibition","display_name":"nuclear export inhibition","score":0.7639999985694885},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.875},{"id":"https://openalex.org/keywords/tumor-sensitization","display_name":"tumor sensitization","score":0.6620000004768372},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6571287512779236},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.641653299331665},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.6190181970596313},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5351797938346863},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5307111144065857},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4939010739326477},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4311037063598633},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3453163206577301},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3174172043800354},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.13301831483840942}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-164443","doi":"https://doi.org/10.1182/blood-2022-164443","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-164443","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4385655665","https://openalex.org/W4405038276","https://openalex.org/W3176946414","https://openalex.org/W2966873510","https://openalex.org/W3141486267","https://openalex.org/W4411397933","https://openalex.org/W7165125535","https://openalex.org/W4320032825","https://openalex.org/W3211889073","https://openalex.org/W4417012501"],"abstract_inverted_index":{"Novel":[0],"therapeutic":[1,75,320],"approaches":[2],"are":[3,39,312],"urgently":[4],"needed":[5],"for":[6,46,76,189,210,315],"many":[7,24],"patients":[8,16,48,57,83],"with":[9,49,182,234,240],"Non-Hodgkin's":[10],"Lymphoma":[11],"(NHL).":[12],"Approximately":[13],"30%":[14],"of":[15,21,44,56,69,78,81,103,134,141,152,198,224,237],"die":[17],"within":[18,66],"5":[19],"years":[20],"diagnosis":[22],"and":[23,95,107,116,260],"more":[25],"relapse.":[26],"Chimeric":[27],"Antigen":[28],"Receptor":[29],"T":[30],"cells":[31,115,157,194,219,297],"(CAR-T)":[32],"directed":[33],"toward":[34],"NHL":[35,82,154,317],"antigens":[36],"(e.g.":[37],"CD19)":[38],"a":[40,53,79,138,149,203,279],"promising":[41],"new":[42],"class":[43],"therapeutics":[45],"some":[47],"relapsed/refractory":[50],"NHL,":[51],"though":[52],"high":[54,323],"percentage":[55],"(~50%)":[58],"still":[59],"fail":[60],"to":[61,92,212,222,252,300],"enter":[62],"remission":[63],"or":[64,202],"relapse":[65],"one":[67],"year":[68],"CD19":[70,113,192,217,301],"CAR-T":[71,114,193,218,253,269,302],"therapy.":[72],"Another":[73],"approved":[74,314],"treatment":[77,167,239],"subtype":[80],"is":[84],"the":[85,132,235,286,295],"nuclear":[86,101],"export":[87,102],"inhibitor,":[88],"selinexor.":[89],"Selinexor":[90],"binds":[91],"exportin":[93],"1":[94,259],"exhibits":[96],"anti-tumor":[97],"activity":[98,119],"by":[99,268],"impairing":[100],"proteins":[104],"including":[105],"oncogenes":[106],"tumor":[108,171,214,225,264,274,283,296],"suppressor":[109],"proteins.":[110],"As":[111,309],"both":[112,135,310],"selinexor":[117,183,241,246,307],"exhibit":[118],"against":[120],"lymphoma":[121],"cells,":[122],"but":[123],"suboptimal":[124],"long":[125],"term":[126],"efficacy":[127,145,233],"in":[128,137,232,282,285],"patients,":[129,318],"we":[130],"assessed":[131,147],"combination":[133,287],"treatments":[136],"mouse":[139],"model":[140,151],"NHL.":[142],"The":[143],"combinatorial":[144],"was":[146,228,248,278],"using":[148],"circulating":[150],"human":[153],"whereby":[155],"RAJI-luciferase":[156],"were":[158,180,207],"intravenously":[159],"injected":[160],"into":[161],"immunocompromised":[162],"mice.":[163],"Initial":[164],"studies":[165],"initiated":[166],"7":[168,272],"days":[169],"post":[170,263,273],"cell":[172,254,265,275,304],"injection.":[173],"Mice":[174,206],"(n=5":[175],"NSG":[176],"mice":[177],"per":[178],"cohort)":[179],"treated":[181],"alone":[184,195,220],"(10mg/kg":[185,256],"gavage":[186,257],"2x":[187],"week)":[188],"study":[190],"duration,":[191],"(single":[196],"injection":[197,255,266,270],"2.5x106":[199],"million":[200],"cells)":[201],"concurrent":[204,238],"combination.":[205],"imaged":[208],"weekly":[209],"bioluminescence":[211],"monitor":[213],"progression.":[215],"While":[216],"led":[221],"inhibition":[223],"growth,":[226],"there":[227,277],"no":[229],"further":[230],"enhancement":[231],"addition":[236],"(Figure":[242,289],"1A).":[243],"Interestingly,":[244],"when":[245],"instead":[247],"administered":[249],"only":[250],"prior":[251],"Day":[258,261,271],"3":[262],"followed":[267],"injection),":[276],"significant":[280],"reduction":[281],"burden":[284],"group":[288],"1B).":[290],"These":[291],"results":[292],"suggest":[293],"that":[294],"become":[298],"sensitized":[299],"mediated":[303],"killing":[305],"from":[306],"administration.":[308],"agents":[311],"FDA":[313],"certain":[316],"this":[319],"strategy":[321],"has":[322],"clinical":[324],"relevance.":[325],"Figure":[326],"1View":[327,330],"largeDownload":[328,331],"PPTFigure":[329],"PPT":[332],"Close":[333],"modal":[334]},"counts_by_year":[{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-30T00:00:00"}